The use of intravenous antibiotics to treat patients at home requires that the therapy be provided safely and cost-effectively. Ideal agents for home use provide the necessary spectrum of ...

including a specific one named meropenem. In simple terms, these bacteria have developed defenses that make powerful antibiotics unable to kill them, making infections caused by these bacteria ...

Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance.

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

and meropenem 10 and 20 mg/mL in NS was stable for at least five days in both containers at 5° C. Carbapenem antibiotics have traditionally been limited to inpatient use for the treatment of ...